|
⚲
|
| Keyboard |
| Knight Jeff E
✚
|
|
|---|---|
| CIK # | 0001881007 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001881007] | |
| 4 | [0001881007] | |
| 5 | [0001881007] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| ALX Oncology Holdings Inc | |
| Knight Jeff E | |
| Crinetics Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2026-03-16 | Sell | 5,950 | $37.11 | 220,804 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2026-03-16 | Sell | 3,961 | $37.77 | 149,607 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2026-02-23 | Grant | 34,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Stock Option (Right to Buy) · derivative
|
2026-02-23 | Grant | 55,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2025-03-19 | Sell | 361 | $34.83 | 12,574 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2025-03-19 | Sell | 6,801 | $34.17 | 232,390 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2025-02-20 | Grant | 43,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Stock Option (Right to Buy) · derivative
|
2025-02-20 | Grant | 65,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-11-22 | Sell | 501 | $56.52 | 28,317 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-07-15 | Option exercise | 2,887 | $20.02 | 57,798 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-07-15 | Option exercise | 5,687 | $19.64 | 111,693 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-07-15 | Sell | 27,000 | $55.00 | 1,485,000 |
|
Crinetics Pharmaceuticals Inc CRNX
Stock option (Right to Buy) · derivative
|
2024-07-15 | Option exercise | 5,687 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Stock option (Right to Buy) · derivative
|
2024-07-15 | Option exercise | 2,887 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Stock option (Right to Buy) · derivative
|
2024-07-15 | Option exercise | 17,499 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-07-15 | Option exercise | 17,499 | $23.98 | 419,626 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-06-26 | Sell | 956 | $44.38 | 42,427 |
|
Crinetics Pharmaceuticals Inc CRNX
Stock Option (right to buy) · derivative
|
2024-03-22 | Option exercise | 30,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-03-22 | Sell | 30,000 | $44.22 | 1,326,600 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-03-22 | Sell | 2,359 | $45.39 | 107,075 |
| showing 20 of 35 most recent transactions | |||||